CND Thematic Discussions on Strengthening Public Health Responses to Drug Use Session 3: High Rates of Transmission of HIV, Hepatitis C Virus and Other Blood-Borne Diseases Associated with Drug Use Evidence Snapshot for the topics of the day – Ms. Chloe Carpentier, Chief, Research and Knowledge Production Section, UNODC: Drug-related infectious diseases – we estimate …
Item 11. Other Business Chair: Excellencies, distinguished delegates, ladies and gentlemen. We will now resume from where we had closed the session before lunch by adopting L10 and we will now proceed to the consideration of L6 rev. 1 as amended by L10. Is the commission ready to adopt L6 rev 1 as amended …
L5 Safety of officers in dismantling illicit synthetic opioid laboratories E/CN.7/2025/L.5 Russia: USA: We ask to ask domestic legislation domestic law OP1 , OP2 Agreed in CoW. OP7 Agreed in CoW. Poland: Can we see the paras with no agreement? PP5 Chair: Can we remove Iran´s reservation? Iran: Yes. Agreed in CoW. …
L6 Strengthening the global drug control framework: a path to effective implementation E/CN.7/2025/L.6 Colombia: we updated the document to reflect all recent agreements from last night, we are still working hard with delegations to find consensus across the document Chair: We start with deliberating the title, the floor is open. Sudan: it was only …
L3. Promoting research on evidence-based interventions for the treatment and care of stimulant use disorders E/CN.7/2025/L.3 (…) Chair: There are several paragraphs in this document that have been agreed during informals, so we will go through those first. PP1 Agreed in CoW. PP4 Agreed in CoW. PP5 Agreed in CoW PP8 Agreed in CoW PP10 …
Item 5. Implementation of the international drug control treaties (continued) (a) Changes in the scope of control of substances Chair: First, Commission will consider recommendations of WHO on 4 substances, namely: (a) Whether or not it wishes to include N-pyrrolidino protonitazene in Schedule I of the 1961 Convention as amended; (b) Whether or not it …